Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...
Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...
Standard methods for additive manufacturing, also known as 3D printing, have major drawbacks with regards to process speed and mechanical strength of the finished product. Standard commercial ...
In the manufacture of biotherapeutic drugs, the goal is to maximize production while minimizing costs, even though achieving this goal may involve a difficult transition—specifically, a transition ...
Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...
COEUR D’ALENE, Idaho--(BUSINESS WIRE)--Continuous Composites announced their opening of a 7,500 sq-foot facility for research, development, and additive manufacturing in Coeur d'Alene, Idaho. The new ...
At a recent meeting in Boston, representatives from global pharmaceutical companies gathered to discuss how to transition from batch to continuous manufacturing. And what company better to learn from ...
Continuous fiber 3D printing and deposition is gaining momentum. As the number of companies using and advancing it grow, this technology will undoubtedly shape the composites industry. First, it ...
Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...
Biologics manufacturers are under increasing pressure to reduce production costs. This is a key driver for moving to continuous processing, which maximizes productivity while minimizing footprint.
Aim: To demonstrate the potential of in-line nanoparticle size measurements using the NanoFlowSizer (NFS) as a PAT method. To achieve real-time process control by establishing automated regulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results